The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis

Saved in:
Bibliographic Details
Published inBlood Vol. 128; no. 1; pp. 138 - 140
Main Authors Leong, Darryl P., Caron, François, Hillis, Christopher, Duan, Annie, Healey, Jeff S., Fraser, Graeme, Siegal, Deborah
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 07.07.2016
Subjects
Agammaglobulinaemia Tyrosine Kinase
Animals
Atrial Fibrillation - chemically induced
Atrial Fibrillation - etiology
Humans
Incidence
Leukemia - drug therapy
Lymphoma - drug therapy
Protein Kinase Inhibitors - adverse effects
Protein Kinase Inhibitors - therapeutic use
Protein-Tyrosine Kinases - antagonists & inhibitors
Pyrazoles - adverse effects
Pyrazoles - therapeutic use
Pyrimidines - adverse effects
Pyrimidines - therapeutic use
Online AccessGet full text

Cover

More Information
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2016-05-712828